Predicting Deterioration - Saving Lives.
February 1, 2018
CardioScale Ltd. Announces that its proprietary CVRI Index has been approved by both the Chinese and Japanese Patent Authorities, giving CardioScale Ltd. a meaningful foothold in Asian markets.
Our Recent Posts
Cardiovascular Reserve Index (CVRI) calculator receives a CE Mark approval
October 14, 2019
Maoz Ben-Ari, CardioScale CEO Interviewed in MedTalk
April 7, 2019
Come see us @ MEDinIsrael2019
March 23, 2019